Annual Drug Patent Expirations for LOKELMA
Lokelma is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are twelve patents protecting this drug.
This drug has one hundred and sixteen patent family members in thirty-five countries.
The generic ingredient in LOKELMA is sodium zirconium cyclosilicate. One supplier is listed for this compound. Additional details are available on the sodium zirconium cyclosilicate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
